What is the main business of Bbbiotech?

The main business activity of Bbbiotech focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on May 19, 2021.

Where is the headquarters located?

The headquarters is located at: Aleja Jana Pawła Ii 61, 01-031 Warszawa.

Who is on the management board?

The management board consists of: Paweł Burzyński (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 100,004 (approx. $27,014).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

In 2024, the company generated total revenue of $199,548, representing an increase of 1939.3% compared to 2023.

Is the company profitable?

No, in 2024 the company was not profitable, reporting a net loss of $359,864. For comparison, in 2023 the loss was $27,215, representing a multi-fold increase in the loss compared to 2023.

What is the main operating cost?

The largest operating cost category falls under external services. This category amounted to $16,805 in 2024, representing 59% of all operating expenses.

BbbiotechS.A.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2021-05-19

Share capital

100 004,00 PLN

Registered address

Aleja Jana Pawła II 61/131, 01-031 Warszawa, Poland

Website

genetly.eu

Electronic delivery address

AE:PL-79910-39326-WIRGG-25

Financials

Revenue history (in k)

Financial insight

Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 3 of 4 financial statements were filed late (the longest delay 90 days for 2021). All were audited by a statutory auditor.

2025not filed
202424/08/2025
202330/03/2024
202230/07/2023
202113/10/2022

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 199.55kMedianUSD 55.24kAverageUSD 2.71m

Net profit

This companyUSD -359.86kMedianUSD -1.27kAverageUSD -91.85k

Operating costs

This companyUSD 28.57kMedianUSD 65.85kAverageUSD 2.66m

Assets

This companyUSD 365.91kMedianUSD 133.19kAverageUSD 3.03m

Industry

Authorized Representatives

Paweł Burzyński – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board is authorised independently to represent the company. In the case of a multi-member management board being appointed, joint action of two members of the management board or one member of the management board jointly with a commercial proxy is required to represent the company.

Supervisory board

Aleksandra Anna Dubik – Supervisory Board Member

Aleksandra Maria Burzyńska – Supervisory Board Member

Ryszard Brudkiewicz – Supervisory Board Member

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2021-07-01.

mBank
08 1140 1010 0000 4340 9700 2001

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Medicofarma BiotechS.A.	$314,882.33	medicofarmabiotech.pl
Explorna Therapeuticssp. z o.o.	$304,662.00	explorna.com
Frontline BiosciencesS.A.	$219,186.29	frontlinebiosciences.com
AI Corelabsp. z o.o.	$128,365.55	aicorelab.com
ModicaP.S.A.	$103,400.72	modica.bio
WPD Pharmaceuticalssp. z o.o.	$90,822.78	wpdpharmaceuticals.com
WPD PharmaceuticalsS.A.	$87,561.70	wpdpharmaceuticals.pl
Stenocoatsp. z o.o.	$36,665.21	stenocoat.com
Platforma Badań Genetycznychsp. z o.o.	$28,558.39	zdrowegeny.pl
Bioselsp. z o.o.	$19,100.32	selol.pl

Change history

Date	Event
2023-05-23	Share capital change (100,003.00 PLN → 100,004.00 PLN)
2021-07-08	Share capital change (100,002.00 PLN → 100,003.00 PLN)
2021-05-19	Entered in the register

FAQ

Last updated: 2026-04-01